A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : CEP17

Search Conditions:
Search Keyword : CEP17
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: CEP17
Appearance Frequency: 21 time(s)
Long forms: 7

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
chromosome enumeration probe 17
(13 times)
Pathology
(7 times)
HER2 (8 times)
FISH (5 times)
IHC (5 times)
2003 Her-2/neu status in breast cancer metastases to the central nervous system.
centromere enumeration probe 17
(2 times)
Neoplasms
(2 times)
ER/PR (1 time)
FISH (1 time)
MLPA (1 time)
2017 Breast carcinomas with low amplified/equivocal HER2 by Ish: potential supporting role of multiplex ligation-dependent probe amplification.
centromeric probe for chromosome 17
(2 times)
Neoplasms
(2 times)
FISH (2 times)
BP (1 time)
H2T (1 time)
2012 Correlation between quantitative HER-2 protein expression and risk for brain metastases in HER-2+ advanced breast cancer patients receiving trastuzumab-containing therapy.
centromere enumeration probe for chromosome 17
(1 time)
Clinical Laboratory Techniques
(1 time)
FISH (1 time)
HER2 (1 time)
2019 The effect of an alternative chromosome 17 probe on fluorescence in situ hybridization for the assessment of HER2 amplification in invasive breast cancer.
centromere part of chromosome 17
(1 time)
Biology
(1 time)
--- 2014 Correlation of HER-2/Neu protein expression and HER2 gene amplification with clinical morphological parameters of nonsmall cell lung cancer.
centromeric probe 17
(1 time)
Breast Neoplasms
(1 time)
ASCO/CAP (1 time)
FISH (1 time)
HER2 (1 time)
2019 Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/CAP ISH group 4 breast cancer.
chromosome probe 17
(1 time)
Neoplasms
(1 time)
GCN (1 time)
HER2 (1 time)
ROC (1 time)
2015 Quantitative assessment of HER2 amplification in HER2-positive breast cancer: its association with clinical outcomes.